Stay updated on Immunotherapy in Surgically Resectable HNSCC Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy in Surgically Resectable HNSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy in Surgically Resectable HNSCC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The clinical trial record for the nivolumab study is displayed, including its study details, participation criteria, treatment arms, locations, and outcome measures.
    Difference
    60%
    Check dated 2026-11-11T17:47:40.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The site footer revision updates from v3.7.2 to v3.8.0, while the study record remains inaccessible behind a 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-28T15:57:42.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A sitewide NIH notice appears above the inaccessible study record, announcing transition updates and a change in terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-21T20:50:07.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2 while the study page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-14T20:46:34.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page continues to display a 403 Forbidden error, while its footer revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T21:00:29.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the expected study content, with a Home link visible for navigation back to the site.
    Difference
    20%
    Check dated 2026-09-30T22:16:48.000Z thumbnail image

Stay in the know with updates to Immunotherapy in Surgically Resectable HNSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy in Surgically Resectable HNSCC Clinical Trial page.